Compare Mutual Funds
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.85
-
NAV
₹599.20
-
Fund Started
10 May 2004
-
Fund Size
₹8365.40 Cr
-
Exit Load
Exit load of 1% if redeemed within 1 month.
-
1 Year
4.96%
-
3 Year
21.76%
-
5 Year
12.63%
-
Equity
98.70%
-
Cash
1.29%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.85% |
Lupin Ltd. | 7.95% |
Dr. Reddy's Laboratories Ltd. | 7.04% |
Divi's Laboratories Ltd. | 6.61% |
Cipla Ltd. | 5.47% |
Apollo Hospitals Enterprise Ltd. | 5.01% |
Medplus Health Services Ltd. | 3.78% |
Vijaya Diagnostic Centre Ltd. | 3.36% |
Sai Life Sciences Ltd. | 3.27% |
Ajanta Pharma Ltd. | 3.19% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
-
Launch Date
10 May 2004
-
